Role of FCγRIIIA and FCγRIIA Receptor Polymorphisms
NCT01827956
·
clinicaltrials.gov ↗
COMPLETED
Status
121
Enrollment
OTHER
Sponsor class
Conditions
Upper Gingival Squamous Cell Carcinoma
Interventions
DRUG:
Cetuximab
Sponsor
Institut Bergonié